• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Diabetes Drugs and Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global diabetes drugs and diagnostics market is currently witnessing strong growth. Diabetes, or diabetes mellitus, refers to a metabolic disorder in which an individual experiences high levels of blood glucose. It is usually caused by inadequate insulin production or a faulty response to insulin in the body. This disorder can lead to chronic health problems, such as cardiovascular diseases (CVDs) and renal, nerve and neural damage. Various anti-diabetic medicines, along with self-monitoring, continuous glucose monitoring and insulin delivery devices, are used for diagnosing the disorder and monitoring its effects in the body. Apart from this, numerous software- and web-based diabetes and blood glucose tracking applications and data management platforms are also being widely used across the healthcare sector.

Global Diabetes Drugs And Diagnostics Market

Owing to the sedentary lifestyle led by a majority of the population, coupled with their unhealthy dietary habits, there is an increasing prevalence of diabetes mellitus across the globe. Furthermore, the rising geriatric population, which is more susceptible to medical ailments, is also contributing to the market growth. In line with this, rising awareness regarding the symptoms and adverse health effects of diabetes has led to the widespread adoption of diabetes diagnosis and drug treatment solutions. Additionally, various technological advancements, such as the development of low-cost and non-invasive insulin delivery systems, wearable devices and digital diabetes management platforms, are acting as another growth-inducing factor. Other factors, including rising disposable incomes, improving healthcare infrastructure and extensive research and development (R&D) activities, are projected to drive the market further.

IMARC Group’s latest report provides a deep insight into the global diabetes drugs and diagnostics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the diabetes drugs and diagnostics market in any manner.

Breakup by Segment:

  • Oral Antidiabetics
    • Breakup by Class
      • Biguanides
      • Alpha-Glucosidase Inhibitors
      • Sodium-Glucose Cotransport -2 Inhibitors (SGLT-2 Inhibitors)
      • Dipeptidyl Peptidase-4 Inhibitors (DPP-4 Inhibitors)
      • Sulfonylureas
      • Dopamine -D2 Receptor Agonist
      • Others
  • Insulin
    • Breakup by Class
      • Long Acting Insulin
      • Fast Acting Insulin
      • Short Acting
      • Others
  • Diabetes Diagnostics
    • Breakup by Product Type
      • Blood Glucose Meters
      • Blood Glucose Strips
      • Lancets
  • Breakup by End-User
    • Hospitals and Clinics
    • Home Healthcare
    • Ambulatory Care Centers
    • Others

Breakup by Region:

  • United States
  • Europe
  • China
  • India
  • Indonesia
  • South Korea
  • Others
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the global diabetes drugs and diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the global diabetes based on the segment?
  • What is the breakup of the global oral anti diabetes market based on class?
  • What is the breakup of the global insulin market based on class?
  • What is the breakup of the global diabetes diagnostics market based on the product type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global diabetes drugs and diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3 Executive Summary
4 Diabetes Disease Overview

    4.1 What is Diabetes?
    4.2 Diabetes Diagnosis and Treatment
        4.2.1 Diagnosis
        4.2.2 Treatment
    4.3 Diabetes Complications
5   Key Factors Driving the Global Diabetes Market
6   Global Diabetes Epidemiology

    6.1 Diabetes Population and Prevalence Rates
    6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    6.3 Population and Prevalence Rates by Region
    6.4 Population and Prevalence Rates by Gender
    6.5 Population and Prevalence Rates by Age Group
7   Global Diabetes Market
    7.1 Historical Market Trends
    7.2 Market Breakup by Segment
    7.3 Market Breakup by Region
    7.4 Market Forecast
    7.5 Top Selling Diabetes Drugs
        7.5.1 Lantus (Sanofi)
        7.5.2 Januvia (Merck And Co)
        7.5.3 Humalog (Eli Lily and Co)
        7.5.4 Novorapid/Novolog (Novo Nordisk)
        7.5.5 Levemir (Novo Nordisk)
        7.5.6 Victoza (Novo Nordisk)
        7.5.7 Janumet (Merck And Co.)
        7.5.8 Humulin (Eli Lily and Co.)
        7.5.9 Toujeo (Sanofi)
7.6 SWOT Analysis
    7.6.1 Overview
    7.6.2 Strengths
    7.6.3 Weaknesses
    7.6.4 Opportunities
    7.6.5 Threats
7.7 Value Chain Analysis
7.8 Porter’s Five Forces Analysis
        7.8.1 Overview
        7.8.2 Bargaining Power of Buyers
        7.8.3 Bargaining Power of Suppliers
        7.8.4 Degree of Competition
        7.8.5 Threat of New Entrants
        7.8.6 Threat of Substitutes
 8 Global Diabetes Market by Segment
    8.1 Global Oral Antidiabetics Market
        8.1.1 Historical Market Trends
        8.1.2 Market Breakup by Class
             8.1.2.1 Biguanides
             8.1.2.2 Alpha-Glucosidase Inhibitors
             8.1.2.3 Sodium-Glucose Cotransport -2 Inhibitors (SGLT-2 Inhibitors)
             8.1.2.4 Dipeptidyl Peptidase-4 Inhibitors (DPP-4 Inhibitors)
             8.1.2.5 Sulfonylureas
             8.1.2.6 Dopamine -D2 Receptor Agonist
             8.1.2.7 Others
        8.1.3 Key Players
        8.1.4 Market Outlook
    8.2 Global Insulin Market
        8.2.1 Historical Market Trends
        8.2.2 Market Breakup by Class
             8.2.2.1 Long Acting Insulin
             8.2.2.2 Fast Acting Insulin
             8.2.2.3 Short Acting
             8.2.2.4 Others
        8.2.3 Key Players
        8.2.4 Market Outlook
    8.3 Global Diabetes Diagnostics Market
        8.3.1 Historical Market Trends
        8.3.2 Market Breakup by Product Type
             8.3.2.1 Blood Glucose Meters
             8.3.2.2 Blood Glucose Strips
             8.3.2.3 Lancets
        8.3.3 Market Breakup by End-User
             8.3.3.1 Hospitals and Clinics
             8.3.3.2 Home Healthcare
             8.3.3.3 Ambulatory Care Centers
             8.3.3.4 Others
        8.3.4 Key Players
        8.3.5 Market Outlook
9 Global Diabetes Market by Region
    9.1 United States
        9.1.1 Historical Market Trends
        9.1.2 Market Outlook
    9.2 Europe
        9.2.1 Historical Market Trends
        9.2.2 Market Outlook
    9.3 China
        9.3.1 Historical Market Trends
        9.3.2 Market Outlook
    9.4 India
        9.4.1 Historical Market Trends
        9.4.2 Market Outlook
    9.5 Indonesia
        9.5.1 Historical Market Trends
        9.5.2 Market Outlook
    9.6 South Korea
        9.6.1 Historical Market Trends
        9.6.2 Market Outlook
    9.7 Others
        9.7.1 Historical Market Trends
        9.7.2 Market Outlook
10 Global Diabetes Market: Competitive Landscape
    10.1 Competitive Structure
    10.2 Key Player Profiles
        10.2.1 Company A
            10.2.1.1 Company Overview
             10.2.1.2 Company Description
             10.2.1.3 Product Portfolio
             10.2.1.4 Key Financials
        10.2.2 Company B
             10.2.2.1 Company Overview
             10.2.2.2 Company Description
             10.2.2.3 Product Portfolio
             10.2.2.4 Key Financials
        10.2.3 Company C
             10.2.3.1 Company Overview
             10.2.3.2 Company Description
             10.2.3.3 Product Portfolio
             10.2.3.4 Key Financials
        10.2.4 Company D
             10.2.4.1 Company Overview
             10.2.4.2 Company Description
             10.2.4.3 Product Portfolio
             10.2.4.4 Key Financials
        10.2.5 Company E
             10.2.5.1 Company Overview
             10.2.5.2 Company Description
             10.2.5.3 Product Portfolio
             10.2.5.4 Key Financials
        10.2.6 Company F
             10.2.6.1 Company Overview
             10.2.6.2 Company Description
             10.2.6.3 Product Portfolio
             10.2.6.4 Key Financials      

List of Figures

Figure 1: The Impact of Diabetes on the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Overweight & Obese Population (in Million), 2014, 2019 & 2025
Figure 4: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 5: Global: Breakup of Diabetes Patients by Region (in %), 2019 & 2025
Figure 6: Global: Total Number of Diabetes Patients (in Millions), 2014-2019
Figure 7: Global: Total Number of Diabetes Patients Forecast (in Millions), 2020 - 2025
Figure 8: Global (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2014-2019
Figure 9: Global (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions) 2020 - 2025
Figure 10: Global: Total Number of Diabetes Patients by Region (in Millions), 2014-2019
Figure 11: Global: Total Number of Diabetes Patients Forecast by Region (in Millions), 2020 - 2025
Figure 12: Global (Male & Female): Total Number of Diabetes Patients (in Millions), 2014-2019
Figure 13: Global (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2020 - 2025 
Figure 14: Global: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in Million), 2014 - 2019
Figure 15: Global: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in Million), 2020 - 2025
Figure 16: Global: Diabetes Drugs and Diagnostics Market: Major Drivers and Challenges
Figure 17: Global: Diabetes Drugs and Diagnostics Market: Value Trends (in Billion US$), 2014-2019
Figure 18: Global: Diabetes Drugs and Diagnostics Market: Breakup by Segment (in %), 2019
Figure 19: Global: Diabetes Drugs and Diagnostics Market: Breakup by Region (in %), 2019
Figure 20: Global: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Million US$), 2020-2025
Figure 21: Global: Oral-Antidiabetics Market: Value Trends (in Million US$), 2014-2019
Figure 22: Global: Oral-Antidiabetics Market: Breakup by Class (in %), 2019
Figure 23: Global: Oral-Antidiabetics Market Forecast: Value Trends (in Billion US$), 2020-2025
Figure 24: Global: Insulin Market: Value Trends (in Million US$), 2014-2019
Figure 25: Global: Insulin Market: Breakup by Class (in %), 2019
Figure 26: Global: Insulin Market Forecast: Value Trends (in Billion US$), 2020-2025
Figure 27: Global: Diabetes Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 28: Global: Diabetes Diagnostics Market: Breakup by Product Type (in %), 2019
Figure 29: Global: Diabetes Diagnostics Market: Breakup by End-User (in %), 2019
Figure 30: Global: Diabetes Diagnostics Market Forecast: Value Trends (in Billion US$), 2020-2025
Figure 31: United States: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 32: United States: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 33: Europe: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 34: Europe: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 35: China: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 36: China: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 37: India: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 38: India: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 39: Indonesia: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 40: Indonesia: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 41: South Korea: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 42: South Korea: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 43: Others: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2014-2019
Figure 44: Others: Diabetes Drugs and Diagnostics Forecast: Value Trends (in Billion US$), 2020-2025
Figure 45: Global: Diabetes Drugs and Diagnostics Market: SWOT Analysis
Figure 46: Global: Diabetes Drugs and Diagnostics Market: Value Chain Analysis
Figure 47: Global: Diabetes Drugs and Diagnostics Market: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Diabetes Drugs and Diagnostics Market: Industry Overview
Table 2: Diagnosis of Diabetes
Table 3: Global: Overweight & Obesity Statistics, 2005, 2010 & 2019
Table 4: Global: Diabetes Population Breakup by Region (in 000’s), 2019 & 2025
Table 5: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 6: Global: Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
Table 7: Global (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
Table 8: Global (Male & Female): Total Prevalence & Number of Diabetes Patients (in Million), 2014, 2019 & 2025
Table 9: Global: Total Prevalence & Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79- in Million), 2014, 2019 & 2025
Table 10: Global: Diabetes Drugs and Diagnostics Market: Key Industry Highlights 2019 and 2025
Table 11: Global: Oral-Antidiabetics Market: Key Industry Highlights 2019 and 2025     
Table 12: Global: Insulin Market: Key Industry Highlights 2019 and 2025
Table 13: Global: Diabetes Diagnostics Market: Key Industry Highlights 2019 and 2025               

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links